Navegar por autor "Iñiguez Romo, Andres"

1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry

2020- Chandrasekhar, J.; Baber, U.; Sartori, S.; Aquino, M. B.; Hájek, P.; [et al.]

1-Year prognosis after unprotected left main coronary artery occlusion treated with primary angioplasty

2012- Salgado Somoza, Antonio; Iñiguez Romo, Andres; De Miguel Castro, Antonio Alejandro; Bastos Fernández, Guillermo; Baz Alonso, José Antonio; [et al.]

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from

2015- Iñiguez Romo, Andres

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

2015- Iñiguez Romo, Andres

A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent-In-Stent Restenosis

2014- Iñiguez Romo, Andres

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Arte

2014- Iñiguez Romo, Andres

Abordaje percutáneo secuencial en una paciente diagnosticada de estenosis aórtica severa y miocardiopatía hipertrófica obstructiva

2011- Iñiguez Romo, Andres; Corujeira Rivera, Carmen; Roman Fernández, Adriana; Arean Gonzalez, Ivan; Pereira Tamayo, Jorge Angel; [et al.]

Acceso radial frente a femoral en angioplastia por infarto agudo de miocardio con elevación del segmento ST con stent farmacoactivo de segunda generación

2015- Iñiguez Romo, Andres

Acute myocardial infarction due to unprotected left main coronary artery occlusion treated with primary angioplasty

2011- Iñiguez Romo, Andres; De Miguel Castro, Antonio Alejandro; Bastos Fernández, Guillermo; Baz Alonso, José Antonio; Ortiz Saez, Alberto; [et al.]

Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression

2012- Iñiguez Romo, Andres

An automated level-set approach for identification of aortic valve borders in short axis windows of transesophageal echo sequences (TEE)

2014- Pazos López, Pablo; Iñiguez Romo, Andres; Paredes Galán, Emilio; Peña Gil, Carlos

Assessment of platelet REACtivity after transcatheter aortic valve replacement

2019- Jimenez Diaz, Victor Alfonso; Tello-Montoliu, Antonio; Moreno, Raul; Cruz Gonzalez, Ignacio; Baz Alonso, Jose Antonio; [et al.]

Clinical evaluation of the Everolimus drug-eluting coronary stent Xience V; For the treatment of de novo coronary lesions in a real practice scenario - Multicentre international SPAREX registry

2011- Iñiguez Romo, Andres

Clinical evaluation of the Everolimus-drug eluting coronary stent Xience v for the treatment of de novo coronary lesions in the daily practice in diabetic patients

2011- Iñiguez Romo, Andres

Clinical Outcome of Nonculprit Plaque Ruptures in Patients With Acute Coronary Syndrome in the PROSPECT Study

2014- Iñiguez Romo, Andres

Clinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: Results from the multinational APTOR registry

2012- Iñiguez Romo, Andres

Clinical profile and outcomes of patients with very late thrombosis after bare-metal stent implantation

2013- Iñiguez Romo, Andres; De Miguel Castro, Antonio Alejandro; Bastos Fernández, Guillermo; Baz Alonso, José Antonio; Ortiz Saez, Alberto; [et al.]

Clopidogrel and acetylsalycilic acid therapy monitoring by liquid chromatography tandem mass spectrometry

2011- Carracedo Álvarez, Ángel; Iñiguez Romo, Andres

Cobalt-Chromium KAname™ coRonary stEnt System in the treatment of patients with coronary artery disease (kare study)

2014- Iñiguez Romo, Andres

Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial

2020- Iñiguez Romo, Andres; Chevalier, B.; Richardt, G.; Neylon, A.; Jiménez Díaz, Victor Alfonso; [et al.]

Repositorio digital RUNA

Navegar por autor "Iñiguez Romo, Andres"

1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry ﻿

1-Year prognosis after unprotected left main coronary artery occlusion treated with primary angioplasty ﻿

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from ﻿

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial ﻿

A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent-In-Stent Restenosis ﻿

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Arte ﻿

Abordaje percutáneo secuencial en una paciente diagnosticada de estenosis aórtica severa y miocardiopatía hipertrófica obstructiva ﻿

Acceso radial frente a femoral en angioplastia por infarto agudo de miocardio con elevación del segmento ST con stent farmacoactivo de segunda generación ﻿

Acute myocardial infarction due to unprotected left main coronary artery occlusion treated with primary angioplasty ﻿

Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression ﻿

An automated level-set approach for identification of aortic valve borders in short axis windows of transesophageal echo sequences (TEE) ﻿

Assessment of platelet REACtivity after transcatheter aortic valve replacement ﻿

Clinical evaluation of the Everolimus drug-eluting coronary stent Xience V; For the treatment of de novo coronary lesions in a real practice scenario - Multicentre international SPAREX registry ﻿

Clinical evaluation of the Everolimus-drug eluting coronary stent Xience v for the treatment of de novo coronary lesions in the daily practice in diabetic patients ﻿

Clinical Outcome of Nonculprit Plaque Ruptures in Patients With Acute Coronary Syndrome in the PROSPECT Study ﻿

Clinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: Results from the multinational APTOR registry ﻿

Clinical profile and outcomes of patients with very late thrombosis after bare-metal stent implantation ﻿

Clopidogrel and acetylsalycilic acid therapy monitoring by liquid chromatography tandem mass spectrometry ﻿

Cobalt-Chromium KAname™ coRonary stEnt System in the treatment of patients with coronary artery disease (kare study) ﻿

Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial ﻿

1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry

1-Year prognosis after unprotected left main coronary artery occlusion treated with primary angioplasty

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent-In-Stent Restenosis

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Arte

Abordaje percutáneo secuencial en una paciente diagnosticada de estenosis aórtica severa y miocardiopatía hipertrófica obstructiva

Acceso radial frente a femoral en angioplastia por infarto agudo de miocardio con elevación del segmento ST con stent farmacoactivo de segunda generación

Acute myocardial infarction due to unprotected left main coronary artery occlusion treated with primary angioplasty

Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression

An automated level-set approach for identification of aortic valve borders in short axis windows of transesophageal echo sequences (TEE)

Assessment of platelet REACtivity after transcatheter aortic valve replacement

Clinical evaluation of the Everolimus drug-eluting coronary stent Xience V; For the treatment of de novo coronary lesions in a real practice scenario - Multicentre international SPAREX registry

Clinical evaluation of the Everolimus-drug eluting coronary stent Xience v for the treatment of de novo coronary lesions in the daily practice in diabetic patients

Clinical Outcome of Nonculprit Plaque Ruptures in Patients With Acute Coronary Syndrome in the PROSPECT Study

Clinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: Results from the multinational APTOR registry

Clinical profile and outcomes of patients with very late thrombosis after bare-metal stent implantation

Clopidogrel and acetylsalycilic acid therapy monitoring by liquid chromatography tandem mass spectrometry

Cobalt-Chromium KAname™ coRonary stEnt System in the treatment of patients with coronary artery disease (kare study)

Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial